A plateau usually indicates that the body has reached a temporary balance point, not that treatment has failed
Early research is looking at whether GLP-1 drugs anti-inflammatory and neurovascular effects could play a role in migraine treatment, not just through weight loss. Because this was an observational study, it cannot prove that GLP-1 drugs caused the lower need for emergency care or additional medications
Long-Term Results: Six Months and Beyond Clinical trials demonstrate that sustained use of GLP-1 medications over twelve to eighteen months can produce average weight loss of fifteen to twenty percent of starting body weight
Notably, 31% of patients on GLP-1 RAs became completely headache-free at 6 months, versus only 8% of those on usual care (this difference did not remain significant after adjusting for weight loss)
The candidate has previously advanced through Phase IIa clinical evaluation in obese patients, as well as Phase I single ascending dose (SAD) studies in healthy volunteers and multiple ascending dose (MAD) studies in diabetic patients
Healthcare practitioners provide glutathione as a shot (by injection into the muscle) to avoid the harmful side effects of cancer treatment (chemotherapy) and to cure infertility (male infertility)
